Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.5983
+0.0375 (6.69%)
At close: Nov 26, 2025, 4:00 PM EST
0.5905
-0.0078 (-1.30%)
After-hours: Nov 26, 2025, 7:58 PM EST

Plus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
5.265.824.910.22-0.3
Upgrade
Revenue Growth (YoY)
-8.16%18.54%2093.30%---95.67%
Upgrade
Cost of Revenue
7.6210.589.699.75.322.7
Upgrade
Gross Profit
-2.37-4.76-4.78-9.47-5.32-2.4
Upgrade
Selling, General & Admin
11.099.948.5410.246.856.41
Upgrade
Operating Expenses
11.099.948.5410.246.856.41
Upgrade
Operating Income
-13.46-14.7-13.32-19.71-12.18-8.8
Upgrade
Interest Expense
-0.61-0.18-0.4-0.71-0.93-1.11
Upgrade
Interest & Investment Income
0.140.270.40.150.020.05
Upgrade
Other Non Operating Income (Expenses)
-6.661.62-00.012.4
Upgrade
EBT Excluding Unusual Items
-20.58-12.98-13.32-20.28-13.08-7.46
Upgrade
Gain (Loss) on Sale of Assets
-----0.07-
Upgrade
Pretax Income
-20.58-12.98-13.32-20.28-13.4-8.24
Upgrade
Earnings From Continuing Operations
-20.58-12.98-13.32-20.28-13.4-8.24
Upgrade
Net Income
-20.58-12.98-13.32-20.28-13.4-8.24
Upgrade
Net Income to Common
-20.58-12.98-13.32-20.28-13.4-8.24
Upgrade
Shares Outstanding (Basic)
4573210
Upgrade
Shares Outstanding (Diluted)
4583210
Upgrade
Shares Change (YoY)
682.06%145.18%79.45%117.18%173.03%219.93%
Upgrade
EPS (Basic)
-0.45-1.95-4.24-11.58-16.63-27.92
Upgrade
EPS (Diluted)
-0.46-2.34-4.24-11.58-16.65-27.92
Upgrade
Free Cash Flow
-15.78-10.7-13.01-13.48-10.42-8.53
Upgrade
Free Cash Flow Per Share
-0.35-1.39-4.14-7.70-12.93-28.89
Upgrade
Gross Margin
-45.00%-81.66%-97.23%---
Upgrade
Operating Margin
-255.91%-252.32%-271.14%-8800.00%--2905.28%
Upgrade
Profit Margin
-391.33%-222.84%-271.04%-9051.34%--2719.80%
Upgrade
Free Cash Flow Margin
-300.06%-183.72%-264.83%-6018.30%--2814.19%
Upgrade
EBITDA
-12.96-13.97-12.69-19.09-11.78-8.44
Upgrade
EBITDA Margin
-246.42%-239.90%-258.35%---
Upgrade
D&A For EBITDA
0.50.720.630.620.40.37
Upgrade
EBIT
-13.46-14.7-13.32-19.71-12.18-8.8
Upgrade
EBIT Margin
-255.91%-252.32%-271.14%---
Upgrade
Revenue as Reported
-----0.3
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q